Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

Published:2009-02 Issue:2 Volume:20 Page:244-250
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Cunningham D.,Sirohi B.,Pluzanska A.,Utracka-Hutka B.,Zaluski J.,Glynne-Jones R.,Koralewski P.,Bridgewater J.,Mainwaring P.,Wasan H.,Wang J.-Y.,Szczylik C.,Clingan P.,Chan R.T.T.,Tabah-Fisch I.,Cassidy J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/2/244/394596/mdn638.pdf

Reference27 articles.

1. The evolution of fluoropyrimidine therapy: from intravenous to oral;Hoff;Oncologist,2001

2. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies;Saif;Oncology (Williston Park),2006

3. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

4. Oxaliplatin: mechanism of action and antineoplastic activity;Raymond;Semin Oncol,1998

5. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers;Raymond;Anticancer Drugs,1997

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysis;Heliyon;2024-08

2. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials;BMC Cancer;2024-07-24

3. Anti-Tumor Efficacy of Oleuropein-Loaded ZnO/Au Mesoporous Silica Nanoparticle in 5-FU-Resistant Colorectal Cancer Cells;International Journal of Nanomedicine;2024-03

4. Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study;European Journal of Cancer;2022-07

5. Acute oral toxicity of damnacanthal and its anticancer activity against colorectal tumorigenesis;Toxicology Reports;2022